相关实验视频

Updated: Jan 13, 2026

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

埃拉米普雷提德改善了 mitochondrial 三功能蛋白缺陷小鼠和人类纤维细胞的线粒体功能

Eduardo Vieira Neto^1,2, Meicheng Wang¹, Austin J Szuminsky³

¹Genetic and Genomic Medicine Division, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Journal of inherited metabolic disease

|January 7, 2026

概括

埃拉米普雷提德改善了三功能蛋白 (TFP) 缺乏,脂肪酸氧化障碍的小鼠的运动耐力. 该药物增强了线粒体功能,独立于心脏蛋白水平,显示了治疗TFP/LCHAD缺乏症的潜力.

科学领域:

生物化学生物化学
线粒体生物学线粒体生物学
代谢障碍代谢障碍代谢障碍

背景情况:

线粒体三功能蛋白 (TFP) 缺乏会损害长链脂肪酸β-氧化 (FAO),导致严重的并发症,如低血糖和心肌病.
现有的治疗方法可以改善一些症状,但不能改善外围神经病变或视网膜病变,特别是孤立的α-TFP (LCHAD) 缺乏症.
在TFP/LCHAD缺乏症中,TFP在心血管蛋白重塑中的作用受损,这表明了新的治疗点.

研究的目的:

调查elamipretide在改善线粒体功能和解决beta-TFP缺乏小鼠和患者衍生纤维细胞中的并发症方面的疗效.
为了确定埃拉米普雷提德的治疗效果是通过心脏脂蛋白水平的变化或通过稳定线粒体酶复合体来调节的.

主要方法:

用elamipretide治疗β-TFP缺乏的小鼠,通过透式迷你,然后进行炼和寒冷压力挑战.
在接受治疗的小鼠中评估肝脏线粒体FAO-ETC酶活动,心脏脂蛋白含量和成分.
评估elamipretide对患者衍生纤维细胞中的线粒体生物能和活性氧物种 (ROS) 的影响.

主要成果:

埃拉米普雷提德在缺乏β-TFP的小鼠中显著改善了运动耐力,尽管寒冷耐受力没有受到影响.
接受治疗的雄性小鼠的肝脏线粒体显示了增强的FAO-ETC酶活性,但心脏脂蛋白水平和组成没有改变.
患者的纤维细胞表现出潜在的基因型依赖于线粒体生物能学的改善,并且在elamipretide治疗下降了ROS产量.

结论:

埃拉米普雷提德通过稳定粮农组织酶和ETC复合体来增强TFP/LCHAD缺乏的线粒体功能,独立于心脏脂蛋白重塑.
这些发现将elamipretide定位为TFP/LCHAD缺乏症的有希望的治疗候选药物,值得进一步进行临床前研究.

关键词:

卡尔迪奥利平因 (cardiolipin) 是一种心脏质蛋白质.埃拉米预想过的是电子运输链复杂蛋白质电子运输链复杂蛋白质脂肪酸氧化过程中的脂肪酸氧化.线粒体中的线粒体.线粒体三功能蛋白质缺乏症线粒体三功能蛋白质缺乏症多种蛋白质的能量复合体.氧化酸化是一种氧化酸化.

更多相关视频

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

相关概念视频

Mitochondrial Precursor Proteins

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...

Translocation of Proteins into the Mitochondria

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...